In Brief
Refine Search
Biotechnology
On Friday, UK health technology assessor the National Institute for Health and Care Excellence (NICE) recommended that US biotech Seagen's Tukysa (tucatinib), in combination with Herceptin (trastuzumab) and capecitabine, be made available for advanced, previously treated, HER2-positive breast cancer patients on the National Health Service (NHS). 26 February 2022
Pharmaceutical
The Tokyo District Court today rendered judgment to deny the plaintiff’s claim in the lawsuit filed on February 17, 2021 regarding the generic drugs to an osteoporosis agent, active vitamin D3 derivative Edirol Capsule (eldecalcitol) based on the patent owned by Japanese pharma major Chugai Pharmaceuticals against Sawai Pharmaceutical, Nichi-Iko Pharmaceutical and Nissan Chemical. 24 February 2022
Pharmaceutical
UK pharma major GlaxoSmithKline says the new company, to result from the proposed demerger of Consumer Healthcare from GSK in mid-2022, will be called Haleon. 23 February 2022
Pharmaceutical
US drugmaker AbbVie has submitted a supplemental New Drug Application (sNDA) for Vraylar (cariprazine) to the US Food and Drug Administration (FDA) for the adjunctive treatment of major depressive disorder (MDD) in patients who are receiving ongoing antidepressant therapy. 23 February 2022
Biotechnology
Cell and gene therapy company Poseida Therapeutics has recruited Brent Warner from Swiss pharma giant Novartis. 22 February 2022
Pharmaceutical
Privately-held UK-based Tetris Pharma has signed a service agreement with Apodi to support the promotion of its lead product in the UK. 22 February 2022
Pharmaceutical
Spanish dermatology specialist Almirall has announced the European commercial launch of Wynzora cream (calcipotriene and betamethasone dipropionate). 18 February 2022
Biotechnology
US biotech Novavax today announced) that Health Canada has granted authorization for Nuvaxovid COVID-19 vaccine (recombinant protein, adjuvanted) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older. 18 February 2022
Pharmaceutical
UK pharma major GlaxoSmithKline today announced that it has voluntarily paused enrolment and vaccination in the GRACE Phase III trial (NCT04605159), evaluating its potential respiratory syncytial virus (RSV) maternal vaccine candidate, as well as two other trials investigating this candidate in pregnant women (NCT04980391, NCT05229068). 18 February 2022
Biotechnology
Sino-American company ShouTi is introducing its discovery engine – Basecamp Bio – to help achieve its aim of creating new oral small molecule treatments for chronic disease using targets currently dominated by biologics. 17 February 2022
Biotechnology
Germany’s BioNTech, the company that has developed Comirnaty, the world’s most successful COVID-19 vaccine in partnership with Pfizer, has taken a next step to improve vaccine supply in Africa. 16 February 2022
Biotechnology
Belgian life sciences investor Newton Biocapital has launched a new fund, NBC II, which will focus on supporting the growth and value creation in preclinical and clinical stage companies, to find solutions for chronic diseases. 15 February 2022
Biotechnology
Pfizer's COVID-19 drug Paxlovid (nirmatrelvir) has received conditional approval in China and Japan on February 14 and February10. 15 February 2022
Pharmaceutical
In 2021, the European Medicines Agency recommended 92 medicines for marketing authorization. Of these, 53 had a new active substance which had never been authorized in the European Union (EU) before. 15 February 2022
Pharmaceutical
Indian drugmaker Dr Reddy's Laboratories entered into an exclusive sales and distribution agreement with Novartis India Limited (NIL) for the Voveran range, the Calcium range and Methergine in India. 14 February 2022
Biotechnology
Pfizer and BioNTech SE plan to extend their rolling submission to the US Food and Drug Administration (seeking to amend the Emergency Use Authorization of the Pfizer-BioNTech COVID-19 Vaccine, also known as Comirnaty, to include children six months through four years of age, which had been requested by FDA. 12 February 2022
Biotechnology
Life sciences and healthcare investment firm, LSP, has raised more than one billion euros ($1.14 billion) for its flagship fund, LSP 7. 11 February 2022
Biotechnology
DNA expert Twist Bioscience is to sell up to $200 million worth of common stock in an underwritten public offering. 10 February 2022
Biotechnology
Asklepios BioPharmaceutical (AskBio) and Touchlight have restructured their joint venture, giving both parties co-exclusive rights to independently supply the adeno-associated virus (AAV) market with doggybone DNA. 8 February 2022
Biotechnology
The year 2021 has set records for the Novo Nordisk Foundation and Novo Holdings, with research grants and investments in established companies scaling new heights at a total of 215 million euros ($246 million). 7 February 2022
Biotechnology
Japanese drugmaker Takeda has launched Fruzaqla (fruquintinib) in its home country. 22 November 2024
Biotechnology
Chinese biopharma CStone Pharmaceuticals has announced a strategic commercial collaboration with Pharmalink Store, a prominent pharmaceutical company based in the United Arab Emirates (UAE). 22 November 2024
Biotechnology
Zhongshan-based biopharma company Akeso will await the verdict of the Chinese medicines regulator on a penpulimab-based combo therapy. 22 November 2024
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Pharmaceutical
Shanghai-based Zai Lab and New York’s Pfizer are to work together on the commercialization of Xacduro (sulbactam-durlobactam) in China. 22 November 2024
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
Biotechnology
California-based venture capital firm Versant Ventures yesterday announced the launch of Pep2Tango Therapeutics, a start-up focused on innovative, next-generation weight loss therapies. Proceeds from the significant, undisclosed round will support development of the company’s novel unimolecular tetra-receptor agonist peptides to treat obesity and related conditions. 22 November 2024
Biotechnology
Hong Kong-based Sino Biopharm has signed an equity investment and strategic collaboration agreement with LaNova Medicines, advancing its oncology focus. 22 November 2024
Biotechnology
British pharma major AstraZeneca is facing challenges in its bid to secure full approval for its anticoagulant reversal therapy, Andexxa (andexanet alfa), in the USA. 22 November 2024
Biotechnology
Colorado, USA-based biotech Enveda Biosciences, which is using AI to translate nature into new medicines, has announced an oversubscribed $130 million Series C funding round led by Kinnevik and FPV. 22 November 2024
Biotechnology
Privately-held US biotech Alloy Therapeutics has announced a strategic collaboration and license agreement with Takeda Pharmaceutical. 21 November 2024
Pharmaceutical
Japanese drugmaker Eisai has announced that the amyotrophic lateral sclerosis (ALS) treatment Rozebalamin for Injection (mecobalamin) has been launched in Japan as a treatment for slowing progression of functional impairment in amyotrophic lateral sclerosis. 21 November 2024
Pharmaceutical
Germany's Merck has spent more than 25 years researching and developing solutions for advancing multiple sclerosis (MS) care. 21 November 2024
Biotechnology
San Diego-based Cidara Therapeutics, a biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, has entered into a securities purchase agreement with certain investors to raise up to around $105 million. 21 November 2024
Pharmaceutical
Swiss pharma giant Novartis today announced an upgrade to its mid-term guidance, in advance of its Meet Novartis Management event for investors and analysts in London. 21 November 2024
Biotechnology
The US Food and Drug Administration (FDA) has granted accelerated approval of Ziihera (zanidatamab-hrii) 50mg/mL for injection for intravenous use, say the drug’s developer, Jazz Pharmaceuticals. 21 November 2024
Biotechnology
Eli Lilly is not resting on its laurels when it comes to the fast-growing field of obesity treatments, an area in which it is already a leader. 21 November 2024
Biotechnology
Aizen Therapeutics, an AI-driven biotech headquartered in San Diego, has officially launched from stealth mode, introducing its drug discovery platform, DaX. 21 November 2024
Biotechnology
San Diego-based Valora Therapeutics, a biotech that boasts of having a novel approach to immunotherapy, has announced the successful closing of a $30 million seed funding round. 21 November 2024
Biotechnology
Astellas Pharma has been hit by bad news from the US Food and Drug Administration, which will not currently approve the firm’s request to supplement the label for Izervay (avacincaptad pegol). 21 November 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze